By Jeff Dale2024-02-21T18:49:00
Barclays disclosed an investigation by the U.K. Financial Conduct Authority (FCA) into the bank’s anti-money laundering (AML) controls closed.
In an annual report filing Tuesday, Barclays said the investigation delved into the bank’s “compliance with U.K. money laundering regulations and the FCA’s rules and principles for businesses.” The probe was focused on “transaction monitoring in relation to certain business lines now in Barclays Bank UK PLC.”
In February 2023, the Financial Times reported the FCA issued a notice in 2022 for an independent review into the bank’s systems to detect and mitigate financial crime following a “concerning” rise in the volume of relatively minor know your customer and AML incidents.
2024-02-28T18:26:00Z By Kyle Brasseur
The U.K. Financial Conduct Authority will rein in its enforcement focus and commit to providing more updates on its ongoing investigations as part of a revamped strategy designed to quicken the pace and increase the deterrent impact of its cases.
2024-02-28T13:17:00Z By Ruth Prickett
Financial firms continue to flout rules designed to protect investors from being misled about the true value of financial products, according to a recent bulletin from the U.K.’s Financial Conduct Authority.
2024-02-23T12:14:00Z By Kyle Brasseur
Lloyds is the latest U.K. financial institution being probed by the Financial Conduct Authority regarding its anti-money laundering control framework.
2025-08-06T20:18:00Z By Aly McDevitt
A delayed product hazard report cost one company criminal and civil penalties—and a mother her life. This case shows why timely reporting and executive accountability are non-negotiable for compliance teams.
2025-08-06T14:00:00Z By Oscar Gonzalez
The Trump administration declawed the Consumer Financial Protection Bureau from the very beginning of his second term. It now appears the agency might be running out of money.
2025-08-05T16:23:00Z By Adrianne Appel
The Securities and Exchange Commission and Department of Justice ended a seven-year review of GE HealthCare Technologies’ China unit for possible violations of the Foreign Corrupt Practices Act.
Site powered by Webvision Cloud